ACP3 and prostate carcinoma: Zimmermann [40] reported that soluble and secreted prostatic acid phosphatase (PAP), an enzyme that has long served as a diagnostic marker for prostate cancer, has a membrane-bound splice variant that exhibits ecto-5′-nucleotidase activity [34].